Aug 7 |
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
|
Aug 7 |
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
|
Aug 6 |
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
|
Aug 5 |
The 3 Best Cannabis Stocks to Buy in August 2024
|
Jul 29 |
Organigram Announces Appointment of Craig Harris to Board of Directors
|
Jul 24 |
Update: Organigram Loses 4.7% as it Completes a Partial Third-Tranche Investment of US$1 Million in Phylos
|
Jul 24 |
Organigram Completes Partial Third Tranche Investment of US$1 Million in Phylos
|
Jul 24 |
Organigram makes partial third tranche investment of $1M in Phylos Bioscience
|
Jul 24 |
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
|
Jul 23 |
US, Canadian pot firms eye Germany for growth as market stagnates at home
|